SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-038359
Filing Date
2020-03-25
Accepted
2020-03-25 17:15:19
Documents
13
Period of Report
2020-03-25
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K tm2013798-1_8k.htm   iXBRL 8-K 36181
  Complete submission text file 0001104659-20-038359.txt   257890

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20200325.xsd EX-101.SCH 3677
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20200325_def.xml EX-101.DEF 27332
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20200325_lab.xml EX-101.LAB 36960
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20200325_pre.xml EX-101.PRE 25944
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2013798-1_8k_htm.xml XML 5162
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 20743122
SIC: 2834 Pharmaceutical Preparations